Dr. Samuel Gandy

Neurologist · Alzheimer's Disease · Brooklyn, New York
  • 336 Publications

Dr. Samuel Gandy and his team are credited with discovering the first drugs that could decrease formation of amyloid, a substance that clogs the brain in Alzheimer’s disease patients, in 1989. His most recent work in 2018 uncovered the discovery that two strains of HIV in the brains of people with Alzheimer’s are twice as high as that found in people without Alzheimer’s.

Dubbed one of GQ magazine’s “Rock Stars of Science” in 2010, he is currently the Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center in New York City, and Chairman Emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association.


Experience

Professor of Alzheimer's Disease Research

Mount Sinai Alzheimer's Disease Research Center in New York City

Professor of Neurology and Psychiatry

Mount Sinai Alzheimer's Disease Research Center in New York City

Associate Director

Mount Sinai Alzheimer's Disease Research Center in New York City


Education

Medical Degree

University of South Carolina

Residency in Neurology

Columbia University

New york presbyterian weill cornell medical center

Internship in Internal Medicine

New York Presbyterian -Weill Cornell Medical Center


Publications

Dr. Samuel Gandy has been involved in 336 publications. View publications ›


Locations

Dr. Samuel Gandy is affiliated with The Mount Sinai Hospital; Center for Cognitive Health at 5 East 98th Street, New York, New York.